Overview:

Summary

Clinical trial report, “Skin Rash Global Clinical Trials Review, Q1, 2011"" provides data on the Skin Rash clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Skin Rash . It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Skin Rash . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Subarachnoid Hemorrhage 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by BRIC Nations 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Unaccomplished Trials of Subarachnoid Hemorrhage 17
Subjects Recruited Over a Period of Time 19
Prominent Sponsors 20
Top Companies Participating in Subarachnoid Hemorrhage Therapeutics Clinical Trials 22
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Codman & Shurtleff, Inc. 24
Clinical Trial Overview of Codman & Shurtleff, Inc. 24
Clinical Trial Overview of Top Universities / Institutes / Hospitals 25
University of Massachusetts 25
Clinical Trial Overview of University of Massachusetts 25
National Taiwan University Hospital 26
Clinical Trial Overview of National Taiwan University Hospital 26
AZIENDA OSPEDALIERA SAN GERARDO 27
Clinical Trial Overview of AZIENDA OSPEDALIERA SAN GERARDO 27
Methodist Healthcare 28
Clinical Trial Overview of Methodist Healthcare 28
University of Washington 29
Clinical Trial Overview of University of Washington 29
Washington University School of Medicine 30
Clinical Trial Overview of Washington University School of Medicine 30
Duke University 31
Clinical Trial Overview of Duke University 31
Columbia University 32
Clinical Trial Overview of Columbia University 32
VU University Medical Center 33
Clinical Trial Overview of VU University Medical Center 33
Thomas Jefferson University 34
Clinical Trial Overview of Thomas Jefferson University 34
University of Cincinnati 35
Clinical Trial Overview of University of Cincinnati 35
University of Wisconsin Madison 36
Clinical Trial Overview of University of Wisconsin Madison 36
Henry Ford Health System 37
Clinical Trial Overview of Henry Ford Health System 37
Kuopio University Hospital 38
Clinical Trial Overview of Kuopio University Hospital 38
University of Michigan 39
Clinical Trial Overview of University of Michigan 39
University of Louisville 40
Clinical Trial Overview of University of Louisville 40
UMC Utrecht 41
Clinical Trial Overview of UMC Utrecht 41
Hospitales Universitarios Virgen del Rocio 42
Clinical Trial Overview of Hospitales Universitarios Virgen del Rocio 42
Chinese University of Hong Kong 43
Clinical Trial Overview of Chinese University of Hong Kong 43
Centre Hospitalier Universitaire de Nice 44
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 44
National Institute of Neurological Disorders and Stroke 45
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 45
Appendix 46
Abbreviations 46
Definitions 46
Research Methodology 47
Secondary Research 48
About GlobalData 48
Contact Us 48
Disclaimer 49
Source 49

List of Tables
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 9
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Asia-Pacific ,Top Countries, 2011* 10
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 11
Subarachnoid Hemorrhage Therapeutics Clinical Trials, North America, Top Countries, 2011* 12
Subarachnoid Hemorrhage Therapeutics Clinical Trials, BRIC Countries, 2011* 13
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials by Phase, 2011* 14
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 15
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 16
Subarachnoid Hemorrhage Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 17
Subarachnoid Hemorrhage Therapeutics Market, Global, Terminated Clinical Trials, 2011* 18
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 22
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 23
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Codman & Shurtleff, Inc., 2011* 24
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2011* 25
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011* 26
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by AZIENDA OSPEDALIERA SAN GERARDO, 2011* 27
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Methodist Healthcare, 2011* 28
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011* 29
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011* 30
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2011* 31
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2011* 32
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2011* 33
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2011* 34
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2011* 35
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2011* 36
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Henry Ford Health System, 2011* 37
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2011* 38
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2011* 39
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2011* 40
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2011* 41
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospitales Universitarios Virgen del Rocio, 2011* 42
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2011* 43
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2011* 44
Subarachnoid Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2011* 45

List of Figures
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 9
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011* 10
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 11
Subarachnoid Hemorrhage Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 12
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 14
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 15
Subarachnoid Hemorrhage Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 16
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 20
Subarachnoid Hemorrhage Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 23
GlobalData Methodology 47